You are viewing the site in preview mode

Skip to main content

Advertisement

Table 4 Tests for melanoma in the last yeara

From: Use of shared care and routine tests in follow-up after treatment for localised cutaneous melanoma

  Stage 0 (n = 36) Stage IA (n = 39) Stage IB (n = 52) Stage IIA (n = 55) Stage IIB/C (n = 48)b Total (n = 230)b,c
Underwent any tests in the past year for surveillance of melanoma 6 (17) 5 (13) 29 (56) 29 (53) 32 (70) 101 (37)
Type of test performedd
 Chest X-ray 0 (0) 1 (3) 10 (19) 11 (20) 9 (20) 31 (11)
 Blood test 2 (6) 3 (8) 8 (15) 13 (24) 13 (28) 39 (13)
 CT scan 0 (0) 0 (0) 6 (12) 10 (18) 14 (30) 30 (8)
 Biopsy 2 (6) 2 (5) 4 (8) 3 (6) 0 (0) 11 (6)
 MRI 1 (3) 0 (0) 1 (2) 1 (2) 1 (2) 4 (2)
 PET scan 1 (3) 0 (0) 3 (6) 4 (7) 7 (15) 15 (5)
 Ultrasonography 0 (0) 1 (3) 9 (17) 9 (16) 9 (20) 28 (10)
 Othere 0 (0) 0 (0) 1 (2) 1 (2) 0 (0) 3 (2)
  1. CT computed tomography, MRI magnetic resonance imaging, PET positron emission tomography
  2. aAll values reported are frequencies (column percentages)
  3. bData are missing for 2 people who are not sure whether they had any tests for melanoma in the past year
  4. cPercentages were adjusted for stratified sampling from the total inception cohort
  5. dSome patients underwent more than one test in the past year